Evidence map›Paper›PMID 27065006›Full record

ArticlePloS one2016

Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats.

Adriaan W Bruijnzeel, Xiaoli Qi, Lidia V Guzhva, Shannon Wall, Jie V Deng, Mark S Gold, Marcelo Febo, Barry Setlow

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Involvement of Adenosine ABrain and behavior · 2026
    Article
  5. Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models.Current topics in behavioral neurosciences · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Effects of acute ΔBrain research · 2024
    Article
  10. Article
  11. Article
  12. ΔDrug and alcohol dependence reports · 2023
    Article
  13. High-THCeNeuro · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Adriaan W BruijnzeelDepartment of Psychiatry, University of Florida, Gainesville, Florida, United States of America.
Xiaoli QiDepartment of Psychiatry, University of Florida, Gainesville, Florida, United States of America.
Lidia V GuzhvaDepartment of Psychiatry, University of Florida, Gainesville, Florida, United States of America.
Shannon WallDepartment of Psychiatry, University of Florida, Gainesville, Florida, United States of America.
Jie V DengDepartment of Psychiatry, University of Florida, Gainesville, Florida, United States of America.
Mark S GoldDepartment of Psychiatry, University of Florida, Gainesville, Florida, United States of America.
Marcelo FeboDepartment of Psychiatry, University of Florida, Gainesville, Florida, United States of America.
Barry SetlowDepartment of Psychiatry, University of Florida, Gainesville, Florida, United States of America.
University of Florida · US

Funding

Using social networks to map and evaluate team science across CTSA hubsUL1TR001427 · NCATS · UNIVERSITY OF FLORIDA · PI MITCHELL, DUANE A. · 2015 to 2024
$37.2M
Lasting behavioral and neuroimaging consequences of adolescent exposure to cannabis smoke.R21DA039349 · NIDA · UNIVERSITY OF FLORIDA · PI BRUIJNZEEL, ADRIAAN WILLEM, SETLOW, BARRY · 2015 to 2016
$410k
NCATS NIH HHS UL1 TR001427NIDA NIH HHS R21 DA039349
6 · The paper itself

Abstract

Cannabis is the most widely used illicit drug in the world. Delta-9-tetrahydrocannabinol (Δ9-THC) is the main psychoactive component of cannabis and its effects have been well-studied. However, cannabis contains many other cannabinoids that affect brain function. Therefore, these studies investigated the effect of cannabis smoke exposure on locomotor activity, rearing, anxiety-like behavior, and the development of dependence in rats. It was also investigated if cannabis smoke exposure leads to tolerance to the locomotor-suppressant effects of the endogenous cannabinoid anandamide. Cannabis smoke was generated by burning 5.7% Δ9-THC cannabis cigarettes in a smoking machine. The effect of cannabis smoke on the behavior of rats in a small and large open field and an elevated plus maze was evaluated. Cannabis smoke exposure induced a brief increase in locomotor activity followed by a prolonged decrease in locomotor activity and rearing in the 30-min small open field test. The cannabinoid receptor type 1 (CB1) receptor antagonist rimonabant increased locomotor activity and prevented the smoke-induced decrease in rearing. Smoke exposure also increased locomotor activity in the 5-min large open field test and the elevated plus maze test. The smoke exposed rats spent more time in the center zone of the large open field, which is indicative of a decrease in anxiety-like behavior. A high dose of anandamide decreased locomotor activity and rearing in the small open field and this was not prevented by rimonabant or pre-exposure to cannabis smoke. Serum Δ9-THC levels were 225 ng/ml after smoke exposure, which is similar to levels in humans after smoking cannabis. Exposure to cannabis smoke led to dependence as indicated by more rimonabant-precipitated somatic withdrawal signs in the cannabis smoke exposed rats than in the air-control rats. In conclusion, chronic cannabis smoke exposure in rats leads to clinically relevant Δ9-THC levels, dependence, and has a biphasic effect on locomotor activity.

Indexed as

AnimalsArachidonic AcidsBehavior, AnimalDrug ToleranceEndocannabinoidsExploratory BehaviorMaleMarijuana AbuseMarijuana SmokingMaze LearningMotor ActivityPolyunsaturated AlkamidesRatsRats, WistarTime FactorsanandamideArachidonic AcidsEndocannabinoidsPolyunsaturated Alkamides

Identifiers

PMID27065006
PMCPMC4827836
OpenAlexW2333897836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.